Denaturation-sensitive BRET probes enable intracellular thermal shift measurements across diverse protein targets and biomolecular complexes
Authors:
Preprint
Abstract
Thermal shift assays have revolutionized drug discovery, but can be limited in sensitivity and scalability. Combining the unique attributes of differential scanning fluorimetry (DSF) and cellular thermal shift (CETSA), we report the methodological framework for the bioluminescence resonance energy transfer shift assay (BRETSA). BRETSA utilizes denaturation sensitive BRET probes, in combination with luciferase-tagged target proteins, to track and longitudinally record thermal shift in living cells. Denaturation profiles were successfully measured for over 500 globular proteins, spanning 24 target families in diverse cellular compartments. Among these, target engagement was confirmed for over 200 proteins; including validated drug targets as well as understudied members of the kinase subfamily. Leveraging orthosteric, allosteric, and covalent ligands in potency studies, this method offers improved sensitivity and scalability compared to other thermal shift methods. We extend the utility of BRETSA to interrogate target engagement at biomolecular complexes and query cooperative binding for molecular glues and emerging tricomplex drug modalities.Funding Information
- Bayer AG
- Genentech
- EU/EFPIA/OICR/McGil/KTH/Diamond Innovative Medicines Initiative 2 Joint Undertaking (EUbOPEN grant 875510)
- Janssen
- Merch KGaA
- Pfizer
- Takeda
This publication has 37 references indexed in Scilit:
- MICRO-TAG enzyme complementation enables quantification of cellular drug-target engagement in temperature seriesSLAS Discovery, 2025
- Discovery and Optimization of a Non-Nucleoside-Based Series of Inhibitors of 2′-Deoxynucleoside 5′-Monophosphate Glycosidase (DNPH1)Journal of Medicinal Chemistry, 2025
- Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted CancersJournal of Medicinal Chemistry, 2025
- Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapiesCell Chemical Biology, 2024
- High-throughput differential scanning fluorimetry (DSF) and cellular thermal shift assays (CETSA): Shifting from manual to automated screeningSLAS Technology, 2023
- Target 2035: probing the human proteomeDrug Discovery Today, 2019
- Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target EngagementCell Chemical Biology, 2018
- Thermal Shift as an Entropy-Driven EffectBiochemistry, 2017
- The scientific impact of the Structural Genomics Consortium: a protein family and ligand-centered approach to medically-relevant human proteinsJournal of Structural and Functional Genomics, 2007
- Lower kinetic limit to protein thermal stability: A proposal regarding protein stability in vivo and its relation with misfolding diseasesProteins: Structure, Function, and Bioinformatics, 2000